Ligand validation:7EVV

PRO: PROLINE

PRO is a Ligand Of Interest in 7EVV designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7EVV_PRO_A_902	90%	48%	0.097	0.981	0.92	1.09	-	-	1	0	100%	1
7FAK_PRO_A_902	93%	46%	0.081	0.977	0.84	1.22	1	1	0	0	100%	1
7VC3_PRO_A_1002	90%	39%	0.095	0.976	0.97	1.42	1	2	0	0	100%	1
7F9R_PRO_A_912	69%	46%	0.112	0.926	0.84	1.22	1	-	0	0	100%	0.93
7FAN_PRO_A_902	69%	39%	0.098	0.91	1.05	1.32	1	2	0	0	100%	1
7FAM_PRO_A_902	65%	39%	0.155	0.958	0.9	1.45	1	1	0	0	100%	1
4N1M_PRO_A_202	100%	55%	0.042	0.992	0.49	1.24	-	1	0	0	100%	1
5MC1_PRO_A_504	96%	42%	0.071	0.978	0.84	1.38	-	2	0	0	100%	1
6MNI_PRO_A_301	94%	49%	0.067	0.968	0.78	1.16	-	1	0	0	100%	1
4UFB_PRO_C_1304	94%	39%	0.075	0.975	0.81	1.54	1	2	0	0	100%	1
2AMF_PRO_C_4331	93%	52%	0.079	0.975	0.67	1.17	-	1	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.